To describe factors associated with provider-ordered influenza testing in hospitalized older adults. DESIGN: Information on participant demographics, symptoms, and provider-ordered influenza testing were collected by questionnaire and chart review. We conducted prospective laboratory-based surveillance using reversetranscriptase polymerase chain reaction (RT-PCR), the criterion standard for diagnosis of influenza, to determine how participant characteristics and provider-ordered testing affected accurate influenza diagnosis. SETTING: One academic and three community hospitals in Davidson County, Tennessee. PARTICIPANTS: Adults aged 18 and older with acute respiratory illness or nonlocalizing fever (N51,422). MEASUREMENTS: We compared characteristics of participants with and without provider-ordered testing for influenza using the Wilcoxon test and Pearson chi-square test. Multivariable logistic regression models were used to identify factors predictive of provider-ordered influenza testing. RESULTS: Twenty-eight percent (399/1,422) of participants had provider-ordered influenza testing. Participants who were tested were younger than those not tested (58 6 18 vs 66 6 15, p<.001) and more likely to have influenza-like illness (ILI) (71% vs 49%, p<.001). ILI decreased with increasing age (aged 18-49, 63%; aged 50-64, 60%; aged 65, 48%). ILI and younger age were independent predictors of provider-ordered testing. Of the 136 participants with influenza confirmed using RT-PCR, ILI was the only significant predictor of provider-ordered testing (adjusted odds ratio53.43, 95% confidence interval51.22-9.70).
I
nfections caused by influenza virus are associated with substantial morbidity and mortality in all age groups, with the highest rates of hospitalization and death in older adults. [1] [2] [3] [4] [5] [6] Prompt recognition, diagnosis, and treatment is predicated upon a suitable case definition of influenza-like illness (ILI), conventionally defined by the Centers for Disease Control and Prevention as fever (temperature 37.88C) and cough or sore throat, 7 but this definition has several limitations in older adults because of comorbid conditions and immunosenescence (aging of the immune system). Adults aged 65 and older may have an attenuated febrile response, possibly due to altered thermoregulatory responses or lower baseline core body temperatures, leading some to suggest revised criteria with a lower fever threshold for suspicion in older adults with suspected influenza. [8] [9] [10] [11] [12] Cognitive deficits that limit ability to communicate symptoms and exacerbations of chronic conditions, particularly cardiac and pulmonary disease, that may dominate clinical presentation may further complicate recognition of influenza in older adults. The effect of these differences on provider-ordered influenza testing is not well known.
We examined the demographic and clinical characteristics of inpatients who underwent provider-ordered influenza testing and compared them with those who were not tested to examine what factors influence influenza testing. Because all participants underwent studyordered reverse-transcriptase polymerase chain reaction (RT-PCR) testing for influenza, those with studyconfirmed influenza virus infection were compared with those who underwent provider-ordered testing to examine what effect testing behaviors had on diagnosis and treatment of influenza virus infections across age groups, particularly age 65 and older.
METHODS

Study Design
Adults hospitalized with symptoms of acute respiratory illness or nonlocalizing fever at four hospitals in Davidson County, Tennessee, were enrolled during each influenza season from November 2006 to April 2012 with the primary goal of evaluating the effectiveness of influenza vaccination in preventing hospitalization. The influenza season was defined as weeks encompassing all laboratoryconfirmed influenza infections in the clinical and research laboratories at Vanderbilt University Medical Center. Two hospitals collected surveillance data during the first two influenza seasons, and four hospitals (one academic, three community) collected data from 2008 to 2012. The 2009 pandemic season was excluded from analyses.
After consent and enrollment in the study, participants or their caregivers completed a questionnaire regarding presenting symptoms and influenza vaccination status. Participants with respiratory illness or fever were further classified as presenting with ILI based on symptoms of cough or sore throat and fever (temperature 37.88C or subjective report of fever or feverishness). Healthcare providers were unaware that participants were enrolled in the study, so any inpatient influenza testing by providers was ordered as part of usual care. Medical records were reviewed using a standardized form to obtain demographic information, history of comorbid medical conditions, results of provider-initiated diagnostic studies, and discharge diagnoses. Provider-ordered influenza tests included rapid antigen detection, PCR, and viral culture tested in the clinical laboratory of their respective institution.
The institutional review boards of Vanderbilt University Medical Center, Sterling, and Western approved the study protocol.
Study Population
Individuals hospitalized with the following admission diagnoses (International Classification of Diseases, Ninth Revision, code) were enrolled-pneumonia (480-486), upper respiratory infection (465), bronchitis (466), influenza (487), chronic obstructive pulmonary disease (490-492, 496), asthma (493), viral illness (079.9), dyspnea (786), acute respiratory failure (518.81), pneumonitis due to solids or liquids (507), and fever (780.6) without localizing symptoms-or if they presented with any of the following symptoms-cough, nonlocalizing fever, shortness of breath, sore throat, and nasal congestion or coryza. Adults aged 50 and older were enrolled for the first two influenza seasons, and those aged 18 and older were enrolled from 2008 onwards.
Laboratory Methods
Midturbinate nose and throat swabs were used to obtain a sample from each participant at the time of enrollment, which was tested for influenza virus in the research laboratory uisng real-time RT-PCR using primers and probes designed by the Centers for Disease Control and Prevention. Confirmed study-ordered influenza-positive cases were defined as positive RT-PCR on duplicate testing of the individual's sample.
Analysis
We compared characteristics of subjects with and without provider-ordered testing for influenza using the Wilcoxon test for continuous variables and Pearson chi-square test for categorical variables. The following variables were prespecified as factors that might affect provider-ordered influenza testing: age (as a continuous variable), race, insurance, underlying medical comorbidities (cardiac disease, chronic obstructive pulmonary disease (COPD) or asthma, and other high-risk conditions), ILI, self-reported vaccination status, and study year. Two multivariable logistic regression models were conducted to assess associations between prespecified factors, provider-ordered influenza testing, and study-ordered influenza-positive tests. Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) were reported. All data analyses were conducted using the statistical computing program R version 3.4.1 (The R Foundation, Vienna, Austria).
RESULTS
Participant Characteristics
Two thousand five hundred fifty-six adults hospitalized with symptoms of acute respiratory illness or nonlocalizing fever were eligible for the study, of whom 1,422 (56%) consented to participate (Table 1) . Although participants were on average younger (63) than those who declined participation (67) (p<.001), enrolled participants were similar to those who declined participation with regard to sex (60% vs 57% female) and race (39% vs 40% white). Of the 1,422 enrolled participants, 48% were aged 65 and older, 39% were white, and 10% were black.
Provider-ordered influenza testing
Provider-ordered influenza testing included antigen detection, viral culture, PCR, or a combination and was ordered in only 28% (399/1,422) of participants presenting with an acute respiratory illness or fever. Forty-one percent (231/561) of participants receiving care in the academic hospital had provider-ordered testing for influenza, compared with 20% (168/861) in the community hospital. Of the 450 provider-ordered tests, 387 (97.0%) were antigen detection, 29 (7.3%) were viral culture, and 34 (8.5%) were PCR detection. Eight percent (32/399) of those who had provider-ordered testing had clinical laboratory-confirmed influenza, representing 2% (32/1,422) of the total population. Of those who had research laboratory testing, 10% (136/1,422) had research laboratory-confirmed influenza, including 77 tested for influenza by their physician and 59 not tested, with 43% (59/136) of those with confirmed influenza according to RT-PCR not tested by their providers. There was no significant variation in proportion of participants tested according to month or season during the influenza seasons included in this study. 13 Provider-ordered testing was more common in younger participants and in those with ILI ( Table 2 ). The mean age of those with provider-ordered influenza testing was 58 6 18 and of those without was 66 6 15 (p<.001).
Of participants who presented with ILI, the mean age of those with provider-ordered influenza testing was 55 6 10 and of those without was 63 6 9 (p5.03). Duration of symptoms on admission was similar in those with provider-ordered testing (4.2 6 7.0 days) and those who were not tested (4.8 6 7.5 days) (p5.15).
Participants with provider-ordered influenza testing were more likely to have presented with fever (73% tested vs 44% not tested, p<.001) and ILI (71% tested vs 49% not tested, p<.001). In all participants, ILI was less common in older adults ( 65, 48%; 50-64, 60%; 18-49, 63%). In participants with study-confirmed influenza, ILI was also less common in older participants ( 65, 74%; 50-64, 83%; 18-49, 81%).
Provider-ordered testing did not differ according to sex or race. A significantly smaller proportion of participants with heart disease and lung disease, including COPD or asthma, underwent provider-ordered influenza testing than of those without these conditions (36% vs 64%, p<.001 and 45% vs 55%, p<.001, respectively). There was no significant difference in comorbid cardiac or pulmonary disease between provider-tested and untested participants who presented with ILI. A larger proportion of those not tested for influenza reported having been vaccinated than of those tested (69% vs 61%, p5.005). The distribution of discharge diagnoses for those tested and not tested for influenza differed significantly (p<.001); although both groups were primarily diagnosed with pneumonia (37% not tested, 41% tested), those not tested for influenza were discharged with proportionally more diagnoses of COPD or asthma (30% vs 20%) and cardiac disease (11% vs 3%).
In individuals presenting with an acute respiratory illness during influenza season, independent factors associated with provider-ordered influenza testing in a multivariable logistic regression model were younger age (aOR52.02, 95% CI51.55-2.63), no history of lung disease (aOR51.68, 95% CI51.26-2.24), and symptoms of ILI (aOR52.22, 95% CI51.71-2.89) ( Table 3 ). In a model of only individuals with confirmed influenza according to study-ordered influenza testing, only ILI was a significant independent factor associated with providerordered influenza testing (aOR53.43, 95% CI51.22-9.70). Finally, participants with provider-ordered testing were more likely to receive treatment with antivirals (6.8% vs 0.2%, p<.001).
DISCUSSION
Provider-ordered testing for influenza was uncommon, and their providers did not order testing for nearly half of participants with confirmed influenza according to RT-PCR. Participants whose providers tested them for influenza tended to be younger and to have presented with ILI. A smaller proportion of older adults presented with ILI than of younger adults, consistent with prior studies examining clinical case definitions for influenza. [8] [9] [10] 14, 15 In our analysis of independent factors associated with influenza .03
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Negative 367 (26) 0 (0) 367 (92) 51 (38) 0 (0) 51 (66) Positive 32 (2) 0 (0) 32 (8) 26 (19) 0 (0) 26 ( (10) 59 (6) 77 (19) 136 (100) 59 (100) 77 ( testing, age was negatively correlated with providerordered testing. In participants who had study-confirmed influenza according to RT-PCR, only ILI was correlated with provider-ordered testing. The known lack of ILI symptoms in older adults may lead to missed influenza diagnoses and missed opportunities for treatment, although even in the subset of older adults who presented with ILI, fewer had provider-ordered influenza testing than younger adults. Although the interaction between age and ILI was not statistically significant, their relationship suggests that ILI presentation alone may not account for the lack of testing. Individuals with cardiac or pulmonary disease were also less likely to have provider-ordered influenza testing, which may simply reflect the many alternative diagnoses for respiratory illness in individuals with underlying disease, although it is conceivable that influenza-associated exacerbations of cardiac or pulmonary conditions are underappreciated in individuals with complex presentations, which is a potential target for physician education and should be considered in guidelines for testing and treatment of influenza in this population. Participants who reported having received the influenza vaccine were less likely to be tested as well, although this was not a significant association in our model. In the United States, vaccination of adults for influenza tends to increase with increasing age, with adults aged 65 and older having the highest vaccination rates. 16 It is uncertain whether providers consistently assess for and use vaccination information to guide clinical decisions, but this might contribute to lower rates of provider-ordered testing in more highly vaccinated populations. Additionally, studies have demonstrated weaker influenza symptoms in adults who have been vaccinated, which may explain some differences in clinical presentation and lead to less provider-ordered testing in individuals who have been vaccinated. 17, 18 The proportion of participants tested at the academic center in our study was more than double the proportion tested in the community hospitals, suggesting a difference in practices between inpatient settings that should be further examined. Another recent study at an academic medical center observed high rates of testing in adults aged 75 and older and higher levels of testing in those with highrisk conditions than in those without comorbidities. 19 The conflicting results of these two studies may reflect differences in testing practices in academic and community hospitals and between academic hospitals, which could be due to clinician factors, institutional practices, or test availability. These findings suggest the need to examine strategies that increase recognition of the need for testing.
A major concern regarding lower rates of influenza testing in older adults is that clinicians are underdiagnosing influenza in a population with substantial morbidity and mortality that could be mitigated uisng early antiviral treatment. 1, 2, [20] [21] [22] A better understanding of the factors involved in provider-ordered testing is needed to determine the barriers to early identification and treatment of infection. Early antiviral treatment improves outcomes and reduces rates of bacterial infection and other complications of respiratory viral illness, and positive tests can minimize overuse of antibiotics and unnecessary diagnostic examination. [20] [21] [22] [23] [24] Despite the current recommendation to use influenza antivirals within 48 hours of symptom onset, our study indicated that fewer than 3% of older adults presenting with an acute respiratory illness and only 11% of those with studyconfirmed influenza received antivirals. 13, 23 Older adults may present later in illness with complications associated with influenza, leading clinicians to forego testing and treatment. This delay could have implications for infection control. Activation of infection control measures that accompany provider-ordered influenza testing reduces nosocomial spread of infection, a benefit that is lost if clinicians do not identify those at risk in the elderly population.
An important consideration after the decision is made to test for influenza is the choice of influenza diagnostic test employed. Rapid antigen tests have been shown to have poor sensitivity in hospitalized older adults, and previous high rates of false negatives may have led physicians to order fewer tests. 24, 25 Despite this, the majority of influenza tests ordered in our study were antigen detection, which may lead to missed cases and underdiagnosis of influenza in this population. The challenge of influenza diagnosis in hospitalized older adults is not only to identify cases clinically, but also to select an appropriately sensitive diagnostic test such as RT-PCR. This test is more sensitive than rapid diagnostic tests employed in the routine diagnostic laboratory, although it are also typically more costly, which may limit its use. 24, 25 There are limitations to this study. Participants were slightly younger than those who did not participate, and thus the data may underrepresent cases of influenza in older adults. Subjects were enrolled at hospitals in Davidson County, Tennessee, and the conclusions may not be generalizable to other care settings, including outpatient practices. Self-report of vaccination may not reflect actual immunization, although others have demonstrated selfreport to be reliable and readily obtainable. 26 Finally, greater availability of new more sensitive and faster molecular diagnostics may affect testing practices in ways that were not examined in this manuscript. Variables included in the multivariable model were age (as a continuous variable), race, insurance, underlying medical comorbidities (cardiac disease, chronic obstructive pulmonary disease or asthma, and other highrisk conditions), influenza-like illness, self-reported vaccination status, and study year.
